2015 annual financial data
Seres Therapeutics 2015 Operating margin
Seres Therapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -54,856,000 USD and net income was -54,780,000 USD.
Operating cash flow was -40,844,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -54,856,000 USD
- Net income
- -54,780,000 USD
- Operating cash flow
- -40,844,000 USD